National Vaccine and Serum Institute, China

NCT05480436

Collaborator, Phase 4, Status unknown, 2022, 1,200 people, 29 Jul 2022, clinicaltrials.gov

NCT05453487

Collaborator, Phase 4, Status unknown, 2022, 360 people, 12 Jul 2022, clinicaltrials.gov

NCT05382871

Collaborator, Phase 3, Status unknown, 2022, 1,804 people, 19 May 2022, clinicaltrials.gov

NCT05374954

Collaborator, Phase 3, Status unknown, 2022, 4,200 people, 16 May 2022, clinicaltrials.gov

NCT05104333

Collaborator, Phase 4, Status unknown, 2021, 1,440 people, 3 Nov 2021, clinicaltrials.gov

NCT05033847

Phase 2, Status unknown, 2021, 1,800 people, 5 Sept 2021, clinicaltrials.gov